Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep;17(9):523-524.
doi: 10.1038/s41571-020-0393-z.

Liquid biopsy for early stage lung cancer moves ever closer

Christian Rolfo  1 , Alessandro Russo  2
Affiliations
Comment

Liquid biopsy for early stage lung cancer moves ever closer

Christian Rolfo et al. Nat Rev Clin Oncol. 2020 Sep.
No abstract available

PubMed Disclaimer

Comment on

  • Integrating genomic features for non-invasive early lung cancer detection.
    Chabon JJ, Hamilton EG, Kurtz DM, Esfahani MS, Moding EJ, Stehr H, Schroers-Martin J, Nabet BY, Chen B, Chaudhuri AA, Liu CL, Hui AB, Jin MC, Azad TD, Almanza D, Jeon YJ, Nesselbush MC, Co Ting Keh L, Bonilla RF, Yoo CH, Ko RB, Chen EL, Merriott DJ, Massion PP, Mansfield AS, Jen J, Ren HZ, Lin SH, Costantino CL, Burr R, Tibshirani R, Gambhir SS, Berry GJ, Jensen KC, West RB, Neal JW, Wakelee HA, Loo BW Jr, Kunder CA, Leung AN, Lui NS, Berry MF, Shrager JB, Nair VS, Haber DA, Sequist LV, Alizadeh AA, Diehn M. Chabon JJ, et al. Nature. 2020 Apr;580(7802):245-251. doi: 10.1038/s41586-020-2140-0. Epub 2020 Mar 25. Nature. 2020. PMID: 32269342 Free PMC article.

References

    1. Shieh, Y. & Bohnenkamp, M. Low-dose CT scan for lung cancer screening: clinical and coding considerations. Chest 152, 204–209 (2017). - DOI
    1. Okereke, I. C., Nishi, S., Zhou, J. & Goodwin, J. S. Trends in lung cancer screening in the United States, 2016–2017. J. Thorac. Dis. 11, 873–881 (2019). - DOI
    1. Rolfo, C. et al. Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC. J. Thorac. Oncol. 13, 1248–1268 (2018). - DOI
    1. Abbosh, C., Birkbak, N. J. & Swanton, C. Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection. Nat. Rev. Clin. Oncol. 15, 577–586 (2018). - DOI
    1. Russo, A. et al. Liquid biopsy tracking of lung tumor evolutions over time. Expert Rev. Mol. Diagn. 19, 1099–1108 (2019). - DOI

LinkOut - more resources